Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes
Authors
Keywords
Kinase inhibitors, Breast cancer, Phenotypes, Gene expression, Library screening, Small molecules, Cell migration, Cancer treatment
Journal
PLoS One
Volume 12, Issue 8, Pages e0177802
Publisher
Public Library of Science (PLoS)
Online
2017-08-04
DOI
10.1371/journal.pone.0177802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth
- (2015) Hassan Al-Ali et al. ACS Chemical Biology
- Metastasis-Free Interval Is Closely Related to Tumor Characteristics and Has Prognostic Value in Breast Cancer Patients with Distant Relapse
- (2015) Hee Jun Kim et al. Journal of Breast Cancer
- Epithelial-Mesenchymal Transition Phenotype Is Associated with Clinicopathological Factors That Indicate Aggressive Biological Behavior and Poor Clinical Outcomes in Invasive Breast Cancer
- (2015) Young Kyung Bae et al. Journal of Breast Cancer
- Src and cortactin promote lamellipodia protrusion and filopodia formation and stability in growth cones
- (2015) Yingpei He et al. MOLECULAR BIOLOGY OF THE CELL
- Comprehensive characterization of the Published Kinase Inhibitor Set
- (2015) Jonathan M Elkins et al. NATURE BIOTECHNOLOGY
- Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells
- (2015) Ashleigh R. Poh et al. Oncotarget
- Abstract 557: Identification of mitogen-activated protein kinases which are required for the growth of triple-negative breast cancers.
- (2014) Graham M. Poage et al. CANCER RESEARCH
- Kinome-wide Functional Analysis Highlights the Role of Cytoskeletal Remodeling in Somatic Cell Reprogramming
- (2014) Kumi Sakurai et al. Cell Stem Cell
- Collective and individual migration following the epithelial–mesenchymal transition
- (2014) Ian Y. Wong et al. NATURE MATERIALS
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Multivariate biophysical markers predictive of mesenchymal stromal cell multipotency
- (2014) Wong Cheng Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional Morphometric Analysis in Cellular Behaviors: Shape and Size Matter
- (2013) Haiyang Yu et al. Advanced Healthcare Materials
- Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy
- (2012) Amye J. Tevaarwerk et al. CANCER
- The evolving landscape of protein kinases in breast cancer: Clinical implications
- (2012) Alberto Ocaña et al. CANCER TREATMENT REVIEWS
- Defining the expressed breast cancer kinome
- (2012) Alicia A Midland et al. CELL RESEARCH
- Regulation of EMT by TGFβ in cancer
- (2012) Carl-Henrik Heldin et al. FEBS LETTERS
- A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma
- (2012) Kian-Ngiap Chua et al. PLoS One
- Evidence for Phenotypic Plasticity in Aggressive Triple-Negative Breast Cancer: Human Biology Is Recapitulated by a Novel Model System
- (2012) Nicholas C. D’Amato et al. PLoS One
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Metastatic Triple-negative Breast Cancer
- (2011) E.A. Rakha et al. CLINICAL ONCOLOGY
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- GOBO: Gene Expression-Based Outcome for Breast Cancer Online
- (2011) Markus Ringnér et al. PLoS One
- Inhibition of Platelet-Derived Growth Factor Receptor Signaling Regulates Oct4 and Nanog Expression, Cell Shape, and Mesenchymal Stem Cell Potency
- (2011) Stephen G. Ball et al. STEM CELLS
- Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk
- (2010) Lyndsay V Rhodes et al. Molecular Cancer
- The (un)targeted cancer kinome
- (2010) Oleg Fedorov et al. Nature Chemical Biology
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
- (2010) J. H. Taube et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
- (2009) Carey K. Anders et al. Clinical Breast Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now